A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa (Q43961862)
Jump to navigation
Jump to search
scientific article published in April 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa |
scientific article published in April 2002 |
Statements
1 reference
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa (English)
1 reference
1 reference
1 reference
E R Brunt
1 reference
J-L Montastruc
1 reference
043 Study Group
1 reference
1 April 2002
1 reference
1 reference
Identifiers
1 reference